DEA Proposes Cutting Production Quotas By 10 Percent For Six Opioids

By Beth Wang / August 16, 2018 at 5:04 PM
The Drug Enforcement Administration (DEA) is proposing to cut manufacturing quotas for oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl by an average of 10 percent for 2019 compared to the 2018 production quotas, the agency announced Thursday (Aug. 16). The six opioids for which DEA is proposing quota cuts in its notice of proposed rulemaking are the most frequently misused and the most commonly prescribed Schedule II opioids, DEA says. When setting annual production quotas, DEA is required to take...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.